Actively Recruiting

Phase Not Applicable
Age: 18Years - 40Years
All Genders
Healthy Volunteers
NCT07221539

Restoration of Consciousness With Ultrasonic Deep Brain Stimulation During Anesthetic Sedation

Led by University of Michigan · Updated on 2025-10-28

168

Participants Needed

1

Research Sites

257 weeks

Total Duration

On this page

Sponsors

U

University of Michigan

Lead Sponsor

N

National Institute of General Medical Sciences (NIGMS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to see if mental functions take place during different levels of anesthesia using two commonly used drug (propofol and dexmedetomidine) and will include low-intensity focused ultrasound pulsation (LIFUP) to stimulate specific areas of the brain while undergoing functional Magnetic Resonance Imaging (fMRI or "brain imaging"), which shows areas in the brain involved in thinking at different depths of anesthesia. That is, ultrasound is being used to stimulate the brain and multiple pictures will be taken of the brain. As a result of this study, we expect to gain a deeper understanding of mental function during different levels of anesthesia, and to evaluate if the use of ultrasonic brain stimulation accelerates return to consciousness.

CONDITIONS

Official Title

Restoration of Consciousness With Ultrasonic Deep Brain Stimulation During Anesthetic Sedation

Who Can Participate

Age: 18Years - 40Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy adults classified as ASA Physical Status 1
  • Right-handed adults
  • Body mass index (BMI) less than 30
  • English speakers
Not Eligible

You will not qualify if you...

  • Unable to undergo MRI scanning due to medical reasons, possible pregnancy, or current breastfeeding
  • Body mass index (BMI) greater than 30
  • Presence of metallic substances in the body, claustrophobia, anxiety, or cardiopulmonary disease
  • Structural brain abnormalities seen on MRI scans
  • Allergy to propofol, dexmedetomidine, eggs, or soy products
  • History of neurological, cardiovascular, or pulmonary illness
  • Significant head injury with loss of consciousness
  • Learning disability or developmental disorders
  • Sleep apnea or severe snoring
  • Gastroesophageal reflux disease (GERD) or heartburn
  • Pancreatitis or history of pancreatitis
  • Sensory or motor loss affecting study participation
  • Epilepsy, seizure disorder, or history of stroke
  • Tattoos on head or neck; other tattoos assessed for safety
  • Recent food or liquid intake within 8 hours
  • History of drug use, positive drug screen, unwillingness to abstain from alcohol for 24 hours before dosing, or current nicotine use
  • Negative pregnancy test required if applicable
  • Participation in another clinical trial with investigational drug or device within past 30 days

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Michigan

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

Loading map...

Research Team

A

Aaron Ellis

CONTACT

A

Amy McKinney

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here